Aquatic Capital Management LLC Reduces Holdings in Schrödinger, Inc. (NASDAQ:SDGR)

Aquatic Capital Management LLC trimmed its position in Schrödinger, Inc. (NASDAQ:SDGR - Free Report) by 58.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,827 shares of the company's stock after selling 23,673 shares during the quarter. Aquatic Capital Management LLC's holdings in Schrödinger were worth $325,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Barclays PLC grew its holdings in shares of Schrödinger by 421.6% during the 3rd quarter. Barclays PLC now owns 107,554 shares of the company's stock valued at $1,995,000 after purchasing an additional 86,933 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Schrödinger by 3.7% during the third quarter. JPMorgan Chase & Co. now owns 122,702 shares of the company's stock worth $2,276,000 after buying an additional 4,403 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Schrödinger by 87.5% during the fourth quarter. GAMMA Investing LLC now owns 2,796 shares of the company's stock worth $54,000 after buying an additional 1,305 shares in the last quarter. Avanza Fonder AB bought a new position in shares of Schrödinger in the 4th quarter valued at $577,000. Finally, Geneos Wealth Management Inc. boosted its holdings in shares of Schrödinger by 15.4% during the 4th quarter. Geneos Wealth Management Inc. now owns 59,996 shares of the company's stock valued at $1,157,000 after acquiring an additional 8,021 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Schrödinger Stock Performance

Shares of NASDAQ:SDGR traded down $0.23 during midday trading on Friday, reaching $23.65. The company's stock had a trading volume of 520,973 shares, compared to its average volume of 838,728. The firm has a market capitalization of $1.73 billion, a price-to-earnings ratio of -10.11 and a beta of 1.84. The firm has a 50 day moving average price of $22.57 and a two-hundred day moving average price of $21.73. Schrödinger, Inc. has a fifty-two week low of $16.60 and a fifty-two week high of $28.47.

Schrödinger (NASDAQ:SDGR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.01). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The firm had revenue of $59.55 million during the quarter, compared to the consensus estimate of $54.60 million. During the same quarter in the previous year, the company posted ($0.86) EPS. The firm's revenue was up 62.7% on a year-over-year basis. As a group, research analysts anticipate that Schrödinger, Inc. will post -2.37 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on SDGR. KeyCorp lifted their price target on Schrödinger from $30.00 to $32.00 and gave the company an "overweight" rating in a research note on Wednesday, April 16th. Piper Sandler lowered their price objective on Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $32.80.

Insider Buying and Selling at Schrödinger

In other news, insider Karen Akinsanya sold 16,723 shares of the company's stock in a transaction on Monday, April 14th. The shares were sold at an average price of $25.09, for a total value of $419,580.07. Following the completion of the sale, the insider now owns 15,625 shares in the company, valued at $392,031.25. This represents a 51.70 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Geoffrey Craig Porges sold 5,491 shares of Schrödinger stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $21.76, for a total transaction of $119,484.16. Following the transaction, the chief financial officer now directly owns 27,544 shares in the company, valued at approximately $599,357.44. This represents a 16.62 % decrease in their position. The disclosure for this sale can be found here. 8.60% of the stock is currently owned by company insiders.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.